Phase 2B Open-Label Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2018
At a glance
- Drugs VDA 1102 (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- Sponsors VidacPharma
- 26 May 2018 Status changed from not yet recruiting to recruiting.
- 15 May 2018 Status changed from planning to not yet recruiting.
- 16 Oct 2017 New trial record